These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26708980)

  • 1. Recurrent Subepidermal Blistering Dermatosis Heralding Disease Relapse in IgA Kappa Multiple Myeloma: Report of a Case and a Review of the Literature.
    Leatham HW; Novoa R; Liedtke M; Kwong BY
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):e1-5. PubMed ID: 26708980
    [No Abstract]   [Full Text] [Related]  

  • 2. Subepidermal bullous dermatosis associated with IgA multiple myeloma: a case report.
    Zhou Q; Jiang H; Zhu K; Han R; Cheng H
    Am J Dermatopathol; 2013 May; 35(3):e49-52. PubMed ID: 23291580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized acquired cutis laxa associated with multiple myeloma with biphenotypic IgG-λ and IgA-κ gammopathy following treatment of a nodal plasmacytoma.
    New HD; Callen JP
    Arch Dermatol; 2011 Mar; 147(3):323-8. PubMed ID: 21422340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA-lambda/IgG-kappa biclonal myeloma in which two clones proliferated in individual sites.
    Ando K; Yaguchi M; Okabe S; Miyazawa K; Ohyashiki K
    Intern Med; 2000 Feb; 39(2):170-5. PubMed ID: 10732840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rapid resolution of pseudohyperphosphatemia in an IGAκ multiple myeloma patient after therapy with a bortezomib-containing regimen: Report of the first case.
    Maden M; Pamuk GE; Asoglu V; Pamuk ON
    J Cancer Res Ther; 2015; 11(4):1043. PubMed ID: 26881672
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired bullous dermatosis associated with IgA multiple myeloma: a case report.
    Barnadas MA; Gelpí C; Martínez L; Curell R; Martino R; Alomar A
    J Cutan Pathol; 2010 Nov; 37(11):1174-7. PubMed ID: 19638068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic esophageal ulcers after autologous hemopoetic stem cell transplant: possible role of IgA levels.
    Dang S; Atiq M; Krishna S; Lamps LW; Olden KW; Aduli F
    Ann Hematol; 2008 Dec; 87(12):1031-2. PubMed ID: 18633617
    [No Abstract]   [Full Text] [Related]  

  • 8. Myeloma with two monoclonal IgG and IgD in serum: a case report.
    Franck P; Petitpain N; Guerci AP; Denisart S; Jacob C; Guéant JL
    Acta Haematol; 1994; 92(3):144-7. PubMed ID: 7871954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
    Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
    Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 71-year-old woman with multiple myeloma status after stem cell transplantation.
    Donato LJ; Zeldenrust SR; Murray DL; Katzmann JA
    Clin Chem; 2011 Dec; 57(12):1645-8. PubMed ID: 22125317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Multiple myeloma with double gammopathy (IgA-kappa, IgA-lambda) : induction of complete remission from plateau phase with interferon-alpha 2a therapy].
    Kanoh T
    Rinsho Ketsueki; 1996 Apr; 37(4):335-9. PubMed ID: 8847805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-incidental presentation of IgA lambda multiple myeloma and pleural involvement with IgM kappa non-Hodgkin's lymphoma.
    Manley R; Monteath J; Patton WN
    Clin Lab Haematol; 1999 Feb; 21(1):61-3. PubMed ID: 10197266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma.
    Halsall DJ; Mangi M; Soos M; Fahie-Wilson MN; Wark G; Mainwaring-Burton R; O'Rahilly S
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2013-6. PubMed ID: 17405845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA multiple myeloma presenting as an acquired bullous disorder.
    Wong DA; Hunt MJ; Stapleton K
    Australas J Dermatol; 1999 Feb; 40(1):31-4. PubMed ID: 10098286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring myeloma: light chain isotype suppression. A new parameter.
    Wearne A; Joshua DE; Kronenberg H
    Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing multiple myeloma: a case report.
    Peterlin P; Ponge T; Blin N; Moreau P; Hamidou M; Agard C
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):373-4. PubMed ID: 21729687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of myelodysplastic syndrome and multiple myeloma.
    Tsiara S; Economou G; Panteli A; Isaakidis P; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 1999 Dec; 18(4):565-6. PubMed ID: 10746986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized linear IgA/IgG bullous dermatosis.
    Shimizu S; Natsuga K; Shinkuma S; Yasui C; Tsuchiya K; Shimizu H
    Acta Derm Venereol; 2010 Nov; 90(6):621-4. PubMed ID: 21057747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interaction of LDL, anti-lipoprotein IgA and human fibroblasts.
    Baudet MF; Dachet C; Beaumont JL
    Biomedicine; 1978 Oct; 29(6):217-20. PubMed ID: 216434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.